Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Toprak

Showing results (21-30 of 43) with videos related to

Pageof 5
Sort By:
Molecular Systems Biology|November 29, 2017
Screening drug effects in patient-derived cancer cells links organoid responses to genome alterationsJulia Jabs, Franziska M Zickgraf, Jeongbin Park, et al.
Life Science Alliance|March 4, 2021
Kalirin-RAC controls nucleokinetic migration in ADRN-type neuroblastomaElena A Afanasyeva, Moritz Gartlgruber, Tatsiana Ryl, et al.
Molecular & Cellular Proteomics : MCP|April 16, 2014
Modulation of the chromatin phosphoproteome by the Haspin protein kinaseAlessio Maiolica, Maria de Medina-Redondo, Erwin M Schoof, et al.
Haematologica|January 20, 2022
Comprehensive genomic analysis of refractory multiple myeloma reveals a complex mutational landscape associated with drug resistance and novel therapeutic vulnerabilitiesNicola Giesen, Nagarajan Paramasivam, Umut H Toprak, et al.
Leukemia|March 23, 2023
Translocation t(6;7) in AML-M4 cell line GDM-1 results in MNX1 activation through enhancer-hijackingDieter Weichenhan, Anna Riedel, Charlotte Meinen, et al.
Ebiomedicine|August 27, 2020
Therapeutic vulnerabilities in the DNA damage response for the treatment of ATRX mutant neuroblastomaSally L George, Federica Lorenzi, David King, et al.
Genes, Chromosomes & Cancer|February 26, 2022
T-cell prolymphocytic leukemia is associated with deregulation of oncogenic microRNAs on transcriptional and epigenetic levelPaurnima Patil, Sina Hillebrecht, Emil Chteinberg, et al.
Nature Cancer|February 5, 2022
Super enhancers define regulatory subtypes and cell identity in neuroblastomaMoritz Gartlgruber, Ashwini Kumar Sharma, Andrés Quintero, et al.
Blood Advances|August 9, 2024
Altered enhancer-promoter interaction leads to MNX1 expression in pediatric acute myeloid leukemia with t(7;12)(q36;p13)Dieter Weichenhan, Anna Riedel, Etienne Sollier, et al.
Nature Communications|November 16, 2018
Whole genome sequencing puts forward hypotheses on metastasis evolution and therapy in colorectal cancerNaveed Ishaque, Mohammed L Abba, Christine Hauser, et al.
Pageof 5

Showing results (21-30 of 43) with videos related to

Sort By:
Pageof 5
Molecular Systems Biology|November 29, 2017
Screening drug effects in patient-derived cancer cells links organoid responses to genome alterationsJulia Jabs, Franziska M Zickgraf, Jeongbin Park, et al.
Life Science Alliance|March 4, 2021
Kalirin-RAC controls nucleokinetic migration in ADRN-type neuroblastomaElena A Afanasyeva, Moritz Gartlgruber, Tatsiana Ryl, et al.
Molecular & Cellular Proteomics : MCP|April 16, 2014
Modulation of the chromatin phosphoproteome by the Haspin protein kinaseAlessio Maiolica, Maria de Medina-Redondo, Erwin M Schoof, et al.
Haematologica|January 20, 2022
Comprehensive genomic analysis of refractory multiple myeloma reveals a complex mutational landscape associated with drug resistance and novel therapeutic vulnerabilitiesNicola Giesen, Nagarajan Paramasivam, Umut H Toprak, et al.
Leukemia|March 23, 2023
Translocation t(6;7) in AML-M4 cell line GDM-1 results in MNX1 activation through enhancer-hijackingDieter Weichenhan, Anna Riedel, Charlotte Meinen, et al.
Ebiomedicine|August 27, 2020
Therapeutic vulnerabilities in the DNA damage response for the treatment of ATRX mutant neuroblastomaSally L George, Federica Lorenzi, David King, et al.
Genes, Chromosomes & Cancer|February 26, 2022
T-cell prolymphocytic leukemia is associated with deregulation of oncogenic microRNAs on transcriptional and epigenetic levelPaurnima Patil, Sina Hillebrecht, Emil Chteinberg, et al.
Nature Cancer|February 5, 2022
Super enhancers define regulatory subtypes and cell identity in neuroblastomaMoritz Gartlgruber, Ashwini Kumar Sharma, Andrés Quintero, et al.
Blood Advances|August 9, 2024
Altered enhancer-promoter interaction leads to MNX1 expression in pediatric acute myeloid leukemia with t(7;12)(q36;p13)Dieter Weichenhan, Anna Riedel, Etienne Sollier, et al.
Nature Communications|November 16, 2018
Whole genome sequencing puts forward hypotheses on metastasis evolution and therapy in colorectal cancerNaveed Ishaque, Mohammed L Abba, Christine Hauser, et al.
Pageof 5